<DOC>
	<DOC>NCT00666705</DOC>
	<brief_summary>An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.</brief_summary>
	<brief_title>A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects</brief_title>
	<detailed_description>Drug interaction study</detailed_description>
	<mesh_term>Maraviroc</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Healthy male and/or female subjects between 18 and 55 years of age. Evidence or history of clinically significant disease or clinical findings at screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>maraviroc</keyword>
	<keyword>raltegravir</keyword>
	<keyword>drug interaction study</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>